Josef H. von Rickenbach, Director at Rein Therapeutics, Inc. (RNTX), bought 47,060 shares at $1.04 ($50K) on 2026-05-21, disclosed to the SEC on 2026-05-28.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Clearly above the average filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $1.04 | 3,420 | $4K | 7.2% |
| 2 | $1.05 | 15,950 | $17K | 33.7% |
| 3 | $1.06 | 23,190 | $24K | 49.4% |
| 4 | $1.07 | 4,500 | $5K | 9.7% |
| Total | $1.05 avg | 47,060 | $50K | 100% |
| Filing → |
| ALRN | BUY | 2019-09-05 | $16K | — | Filing → |
| ALRN | BUY | 2019-09-04 | $20K | — | Filing → |
| ALRN | BUY | 2019-09-03 | $3K | — | Filing → |